{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:21:07Z","timestamp":1788445267124,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA0917104"],"award-info":[{"award-number":["2024YFA0917104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQN26B020007"],"award-info":[{"award-number":["LQN26B020007"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22378360"],"award-info":[{"award-number":["22378360"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22508354"],"award-info":[{"award-number":["22508354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bmcl.2026.130759","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:06:51Z","timestamp":1786518411000},"page":"130759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates for enhanced photodynamic therapy in triple-negative breast cancer"],"prefix":"10.1016","volume":"141","author":[{"given":"Jinhui","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130759_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA-Cancer J Clin"},{"key":"10.1016\/j.bmcl.2026.130759_bb0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus chemotherapy in advanced triple-negative breast Cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2026.130759_bb0015","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab Govitecan in metastatic triple-negative breast Cancer","volume":"384","author":"Bardia","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2026.130759_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.bmcl.2026.130759_bb0025","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2026.130759_bb0030","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","article-title":"Photodynamic therapy - mechanisms, photosensitizers and combinations","volume":"106","author":"Kwiatkowski","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmcl.2026.130759_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201600106","article-title":"Chemophototherapy: an emerging treatment option for solid Tumors","volume":"4","author":"Luo","year":"2017","journal-title":"Adv Sci"},{"key":"10.1016\/j.bmcl.2026.130759_bb0040","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/med.21935","article-title":"Photodynamic therapy: innovative approaches for antibacterial and anticancer treatments","volume":"43","author":"Kolarikova","year":"2023","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmcl.2026.130759_bb0045","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.3390\/ijms23147974","article-title":"A recap of Heme metabolism towards understanding protoporphyrin IX selectivity in Cancer cells","volume":"23","author":"Kiening","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2026.130759_bb0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/bs.adioch.2017.03.002","article-title":"Chapter nine - reactive oxygen species in photodynamic therapy: mechanisms of their generation and potentiation","volume":"70","author":"D\u0105browski","year":"2017","journal-title":"Adv Inorg Chem"},{"key":"10.1016\/j.bmcl.2026.130759_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/1011-1344(90)85083-9","article-title":"Photodynamic therapy with endogenous protoporphyrin: IX: basic principles and present clinical experience","volume":"6","author":"Kennedy","year":"1990","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.bmcl.2026.130759_bb0060","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1365-2133.2003.05600.x","article-title":"Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment","volume":"149","author":"Horn","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.bmcl.2026.130759_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135896","article-title":"Identification of the mitochondrial Heme metabolism complex","volume":"10","author":"Medlock","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bmcl.2026.130759_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001127","article-title":"Ferroportin and iron regulation in breast cancer progression and prognosis","volume":"2","author":"Pinnix","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bmcl.2026.130759_bb0075","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmcl.2026.130759_bb0080","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1158\/0008-5472.CAN-20-2017","article-title":"Iron and Cancer: 2020 vision","volume":"80","author":"Torti","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmcl.2026.130759_bb0085","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/cas.15637","article-title":"Polymeric iron chelators for enhancing 5-aminolevulinic acid-induced photodynamic therapy","volume":"114","author":"Nomoto","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bmcl.2026.130759_bb0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/1011-1344(95)07117-K","article-title":"Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice","volume":"28","author":"Malik","year":"1995","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.bmcl.2026.130759_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci8120203","article-title":"Augmentation of 5-Aminolevulinic acid treatment of glioblastoma by adding ciprofloxacin, deferiprone, 5-fluorouracil and febuxostat: the CAALA regimen","volume":"8","author":"Kast","year":"2018","journal-title":"Brain Sci"},{"key":"10.1016\/j.bmcl.2026.130759_bb0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.redox.2016.07.002","article-title":"The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species","volume":"9","author":"Dogra","year":"2016","journal-title":"Redox Biol"},{"key":"10.1016\/j.bmcl.2026.130759_bb0105","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1021\/acs.jmedchem.7b00346","article-title":"Hydroxypyridinone and 5-aminolaevulinic acid conjugates for photodynamic therapy","volume":"60","author":"Battah","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130759_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117726","article-title":"Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates","volume":"105","author":"Zhang","year":"2024","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2026.130759_bb0115","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/ja954126l","article-title":"Ruthenium(II)-catalyzed asymmetric transfer hydrogenation of ketones using a formic acid\u2212triethylamine mixture","volume":"118","author":"Fujii","year":"1996","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2026.130759_bb0120","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1039\/b102895m","article-title":"Enantioselective synthesis of \u03b2-hydroxy amines and aziridines using asymmetric transfer hydrogenation of \u03b1-amino ketones","volume":"30","author":"Kawamoto","year":"2001","journal-title":"J Chem Soc, Perkin Trans 1"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2600226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2600226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:09:35Z","timestamp":1788444575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2600226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":24,"alternative-id":["S0960894X2600226X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130759","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates for enhanced photodynamic therapy in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130759"}}